Sep 19, 2024, 09:09
Stephanie Graff: Results of DESTINY-Breast12 from ESMO24
Stephanie Graff, Director Breast Oncology at Lifespan Cancer Institute, shared a post on X:
“DESTINY breast 12 by Nancy Lin at ESMO24
- 12 month PFS overall, similiar w stable and active brain mets 62.9% & 59.6%
- median PFS = 17.3 mon
- CNS ORR = 71.7%
- 12-month OS was maintained in patients with BMs (90.3%) and without BMs (90.6%).”
Source: Stephanie Graff/X
Stephanie Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University and co-leader of the Breast Cancer Translational Research Disease Group. She is an Associate Professor of Medicine at the Warren-Alpert School of Medicine. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research, is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12